Literature DB >> 3732095

Diuretic therapy for hypertension in the elderly.

M G Myers.   

Abstract

Recent studies have confirmed the benefits of treating hypertension in the elderly. Thiazide diuretics appear to be effective in achieving goal blood pressure in a majority of patients above the age of 60 years. Increasing concern regarding the biochemical abnormalities associated with diuretic therapy has led to the more widespread use of lower doses of these agents. Preliminary results from a study of hydrochlorothiazide +/- amiloride treatment in 99 hypertensive patients aged 65 to 80 years indicate that hydrochlorothiazide 25 to 50 mg/day will lower diastolic blood pressure to less than 90 mmHg in about 90% of elderly patients with mild to moderate elevations in blood pressure. These lower dosages of hydrochlorothiazide were only occasionally associated with mild hypokalaemia. However, the addition of amiloride to the treatment regimen resulted in the maintenance of normal serum potassium concentrations. Thus, relatively low doses of thiazide diuretics may effectively lower blood pressure in elderly hypertensive patients while causing fewer biochemical abnormalities than previously associated with the use of these drugs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3732095     DOI: 10.2165/00003495-198600314-00022

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  24 in total

1.  Antihypertensive therapy in patients above age 60. Third interim report of the European Working Party on High blood pressure in Elderly (EWPHE).

Authors:  A Amery; P Berthaux; W Birkenhäger; A Boel; P Brixko; C Bulpitt; D Clement; M Deruyttere; A de Schaepdryver; C Dollery; R Fagard; F Forette; J F Henry; J Hellemans; U Laaser; P Lund-Johansen; J MacFarlane; T Maling; A Mutsers; A Nissinen; O H Ohn; J Pelemans; A I Suchettkaye; J Tuomilehto; J Willems
Journal:  Acta Cardiol       Date:  1978       Impact factor: 1.718

2.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

3.  Adrenaline and potassium: everything in flux.

Authors: 
Journal:  Lancet       Date:  1983-12-17       Impact factor: 79.321

4.  Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up.

Authors:  M B Murphy; P J Lewis; E Kohner; B Schumer; C T Dollery
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

5.  MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

6.  Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1979-12-07       Impact factor: 56.272

7.  Aging and heavy drug use: a prescription survey in Manitoba.

Authors:  F Y Aoki; V K Hildahl; G W Large; P A Mitenko; D S Sitar
Journal:  J Chronic Dis       Date:  1983

8.  Chlorthalidone in mild hypertension - dose response relationship.

Authors:  J G Russell; S R Mayhew; I S Humphries
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Hypokalaemia and ventricular fibrillation in acute myocardial infarction.

Authors:  J E Nordrehaug; G von der Lippe
Journal:  Br Heart J       Date:  1983-12

10.  Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension.

Authors:  J W Hollifield
Journal:  Am J Med       Date:  1984-11-05       Impact factor: 4.965

View more
  1 in total

Review 1.  Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence.

Authors:  A W Hoes; D E Grobbee; T M Peet; J Lubsen
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.